Search

The influence of peptidylglycine alpha-amidating monooxygenase (PAM) and of its co-factor, ascorbate, were studied in relation to thyroliberin (TRH) activity during mouse hypothalamus development. In vivo, PAM activity developed slowly at fetal stages, and exhibited a sharp rise around the 5th-8th postnatal day, the adult level being reached around day 15. The same developmental pattern was observed when studied in serum-free cultures initiated from fetal mouse hypothalamus. Using this in vitro model, we investigated the effects of ascorbate, a necessary co-factor of PAM, on TRH. Upon ascorbate supplementation of the culture medium, the TRH accumulation normally occurring in our cultures was further enhanced. The half maximum effect was attained with 20 microM, and the amplitude of the response to ascorbate was maximum around 9-13 days in vitro. Moreover, ascorbate increased to an even larger extent the amounts of TRH released upon chemical depolarization. These results are consistent with a direct role of ascorbate on PAM activity, but other more general effects on the maturation of the neuronal response to physiological stimuli cannot be excluded.

The intracellular mechanisms regulating the process of thyroliberin (TRH) release were studied using fetal hypothalamic neurons grown in serum-free medium. In particular, we compared the effects of dihydropyridine (DHP) derivatives, omega-conotoxin and phorbol esters on basal and K+-evoked TRH release from 12 days in vitro (DIV) neurons. BAY K 8644, a DHP calcium channel agonist increased in a dose-related manner basal and K+-evoked TRH release. PN 200-110, an antagonist of DHP-sensitive calcium channels, completely suppressed the effect of BAY K 8644, whatever the extracellular K+ concentration, but did not modify basal or K+-evoked TRH release. In contrast, omega-conotoxin partially inhibited the two latter processes. The active phorbol ester 12-O-tetradecanoyl-phorbol-beta-acetate (TPA), and to a lesser extent Sn-1,2-dioctanoylglycerol (DAG), triggered TRH release. This effect was specific, time and dose dependent and only partly dependent on extracellular calcium. Simultaneous addition of BAY K 8644 and TPA to the cells displayed a synergistic effect. The same compounds were studied on younger neurons (6-DIV cultures): BAY K 8644 stimulated TRH release whereas neither 60 mM K+ nor TPA did. These results suggest that TRH release can be mediated at least by two intracellular routes: (i) increase of intracellular calcium mediated by the opening of different types of voltage sensitive calcium channels, and (ii) activation of protein kinase C (PKC). The asynchrony in the maturation of the intracellular mechanisms underlying TRH release may be explained by different subcellular localizations of these mechanisms in neurons and is discussed in relation to synapse differentiation.

Serum-free cultures of mouse mesencephalic cells were used for studying the influence of triiodothyronine (T3) on the morphogenesis of dopaminergic neurons. Supplementation of culture medium with T3 (10(-9) M) did not modify the number, but increased the size of the perikarya without affecting the neurite density of mesencephalic dopamine (DA) neurons. Furthermore, T3 had no effect on the uptake of [3H]DA in these cultures. These findings, taken together with previous results obtained with hypothalamic cell cultures, show that T3 affects the morphogenesis of mesencephalic DA neurons in a different manner than that of hypothalamus and that the perikarya size on the one hand, and the neurite elongation on the other hand, seem to be independently regulated by T3.

Serum-free cultures of mouse hypothalamic cells were used as a model for studying TRH (thyroliberin) secretion in vitro. Supplementation of the culture medium with triiodothyronine, corticosterone and polyunsaturated fatty acids is necessary to obtain a substantial release capacity of TRH neurons. Under these conditions depolarization of the cells with 60 mM K+ results in a calcium-dependent release of immunoreactive TRH.